TRANSCODE THERAPEUTICS INC (RNAZ)
US89357L3033 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to RNAZ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 122.4. This target is 14826.83% above the current price.
RNAZ was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RNAZ.
In the previous month the buy percentage consensus was at a similar level.
RNAZ was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2022-11-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-07 | HC Wainwright & Co. | Initiate | Buy |